Chelation therapy with intravenous injections of edetate disodium is being promoted to the public as a nonsurgical means to treat coronary or other arterial atherosclerosis. The rationale for use, clinical efficacy, and safety are reviewed. Acceptable evidence supporting chelation therapy for atherosclerotic vascular disease is lacking.
StevensonJGCovingtonTR. Chelation therapy in atherosclerosis. Ann Intern Med1982; 97: 789–90.
2.
LamarCP. Chelation endarterectomy for occlusive atherosclerosis. J Am Geriatr Soc1966; 14: 272–94.
3.
ClarkeNEClarkeCNMosherRE. The “in vivo” dissolution of metastatic calcium: An approach to atherosclerosis. Am J Med Sci1955; 229: 142–9.
4.
PerryHMSchroederA. Depression of cholesterol levels in human plasma following ethylenediamine tetraacetate and hydralazine. J Chron Dis1955; 2: 520–33.
5.
LamarCP. Chelation therapy of occlusive arteriosclerosis in diabetic patients. Angiology1964; 15: 379–95.
6.
ClarkeNE. Atherosclerosis, occlusive vascular disease and EDTA. Am J Cardiol1960; 5: 233–6.
CasdorphHR. EDTA chelation therapy. II. Efficacy in brain disorders. J Holistic Med1981; 3: 101–17.
9.
RossRGlomsetJA. The pathogenesis of atherosclerosis. N Engl J Med1976; 295: 369–78, 420–5.
10.
MoonHDRinehartJF. The histogenesis of coronary arteriosclerosis. Circulation1952; 6: 481–8.
11.
WisslerRW. Atherosclerosis—its pathogenesis in perspective. Adv Cardiol1974; 13: 10–31.
12.
ClarkeNEClarkeCNMosherRE. Treatment of angina pectoris with disodium ethylene diamine tetraacetic acid. Am J Med Sci1956; 232: 654–66.
13.
KitchellJRMeltzerLESevenMJ. Potential uses of chelation methods in the treatment of cardiovascular disease. Prog Cardiovasc Dis1961; 3: 338–49.
14.
MeltzerLEKitchellJRPalmonFJrThe long term use, side effects, and toxicity of disodium ethylenediamine tetraacetic acid (EDTA). Am J Med Sci1961; 242: 51–7.
15.
RobinsonDM. Chelation therapy (letter). NZ Med J1982; 95: 750.
16.
KitchellJRPalmonFJrAytanNMeltzerLE. The treatment of coronary artery disease with disodium EDTA: A reappraisal. Am J Cardiol1963; 11: 501–6.
17.
DerSimonianRCharetteLJMcPeekBMostellerF. Reporting on methods in clinical trials. N Engl J Med1982; 306: 1332–7.
18.
SofferASpencerHRubinNChelation therapy. Springfield, IL: Charles C. Thomas, 1964.
19.
SevenMJ, ed. Metal binding in medicine. Philadelphia: Lippincott, 1960.
20.
SteelKFeldmanRG. Diagnosing dementia and its treatable causes. Geriatrics1979; 34: 79–88.
21.
GershonSHermanSP. The differential diagnosis of dementia. J Am Geriatr Soc1982; 30: 858–61.
22.
McDonaghEWRudolfCJCheraskinE. An oculocerebrovasculometric analysis of the improvement in arterial stenosis following EDTA chelation therapy. J Holistic Med1982; 4: 21–3.
23.
CasdorphHRFarrCH. EDTA chelation therapy. III. Treatment of peripheral arterial occlusion, an alternative to amputation. J Holistic Med1983; 5: 3–15.
24.
MoelDIKumarK. Reversible nephrotoxic reactions to a combined 2, 3-dimercapto-1-propanol and calcium disodium ethylenediaminetetraacetic acid regimen in asymptomatic children with elevated blood lead levels. Pediatrics1982; 70: 259–62.
25.
HollandJFDanielsonESahagian-EdwardsA. Use of ethylene diamine tetraacetic acid in hypercalcemic patients. Proc Soc Exp Biol Med1953; 84: 359–64.
26.
DudleyHRRitchieACSchillingABakerWH. Pathologic changes associated with the use of sodium ethylene diamine tetraacetate in the treatment of hypercalcemia: Report of two cases with autopsy findings. N Engl J Med1955; 255: 331–7.
27.
AltmanJWakimKGWinkelmannRK. Effects of edathamil disodium on the kidney. J Invest Dermatol1961; 36: 215–8.
28.
DePalma v Levin. US District Court, EDNY, No 78 Civ 227, 2 Nov 1981.
29.
AMA Division of Drugs.AMA drug evaluations, 5th ed.Chicago:American Medical Association, 1983.
30.
MeltzerLEPalmonFPJrKitchellJR. Hypoglycemia induced by ethylenediamine tetra-acetic acid. Lancet1961; 2: 637–8.
31.
PetersonGR. Adverse effects of chelation therapy (letter). JAMA1983; 250: 2926.
32.
Diagnostic and therapeutic technology assessment (DATTA): chelation therapy.JAMA1983; 250: 672.
33.
EDTA chelation therapy for atherosclerotic heart disease.Med Lett Drugs Ther1981; 23: 51.
